Introducing the first FDA approved rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen. This 4th generation test has the ability to identify HIV earlier than 2nd and 3rd generation antibody-only tests.1 It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.
Now CLIA-Waived for fingerstick whole blood!
Only available in the US.